-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Initiates Coverage On Taysha Gene Therapies with Buy Rating, Announces Price Target of $8

Benzinga·07/11/2025 12:20:43
Listen to the news
B of A Securities analyst Tazeen Ahmad initiates coverage on Taysha Gene Therapies (NASDAQ:TSHA) with a Buy rating and announces Price Target of $8.